ArticlePloS one2018

Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.

Davina Gale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.